These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9692778)

  • 1. Systemic and renal effects of an ET(A) receptor subtype-specific antagonist in healthy subjects.
    Schmetterer L; Dallinger S; Bobr B; Selenko N; Eichler HG; Wolzt M
    Br J Pharmacol; 1998 Jul; 124(5):930-4. PubMed ID: 9692778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin ETA receptor-subtype specific antagonism does not mitigate the acute systemic or renal effects of exogenous angiotensin II in humans.
    Bayerle-Eder M; Langenberger H; Pleiner J; Polska E; Mensik C; Eichler HG; Wolzt M; Schmetterer L
    Eur J Clin Invest; 2002 Apr; 32(4):230-5. PubMed ID: 11952807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The renal and systemic hemodynamic effects of a nitric oxide-synthase inhibitor are reversed by a selective endothelin(a) receptor antagonist in men.
    Schmidt A; Bayerle-Eder M; Pleiner H; Zeisner C; Wolzt M; Mayer G; Schmetterer L
    Nitric Oxide; 2001 Aug; 5(4):370-6. PubMed ID: 11485375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic ETA receptor antagonism with BQ-123 blocks ET-1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy men.
    Spratt JC; Goddard J; Patel N; Strachan FE; Rankin AJ; Webb DJ
    Br J Pharmacol; 2001 Oct; 134(3):648-54. PubMed ID: 11588120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal actions of endothelin-1 in newborn piglets: dose-effect relation and the effects of receptor antagonist (BQ-123) and cyclooxygenase inhibitor (indomethacin).
    Bhat R; John E; Chari G; Shankararao R; Fornell L; Gulati A; Vidyasagar D
    J Lab Clin Med; 1995 Nov; 126(5):458-69. PubMed ID: 7595031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ETA receptor-mediated responses to endothelin-1 and big endothelin-1 in the rat kidney.
    Pollock DM; Opgenorth TJ
    Br J Pharmacol; 1994 Mar; 111(3):729-32. PubMed ID: 8019752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of BQ-123 on systemic and renal hemodynamic responses to endothelin-1 in the rat split hydronephrotic kidney.
    Cavarape A; Bartoli E
    J Hypertens; 1998 Oct; 16(10):1449-58. PubMed ID: 9814615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: a comparison of selective and combined endothelin receptor blockade.
    Goddard J; Johnston NR; Hand MF; Cumming AD; Rabelink TJ; Rankin AJ; Webb DJ
    Circulation; 2004 Mar; 109(9):1186-93. PubMed ID: 14981006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of BQ-123, an endothelin antagonist, on renal hemodynamics, tubular function, vasoactive hormones, and blood pressure in healthy humans: a dose response study.
    Pedersen EB; Thomsen IM; Fjordside LS
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1578-85. PubMed ID: 16364829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal haemodynamic effects of endothelin-1 and the ETA/ETB antagonist TAK-044 in anaesthetized rabbits.
    Evans RG; Bergström G; Cotterill E; Anderson WP
    J Hypertens; 1998 Dec; 16(12 Pt 2):1897-905. PubMed ID: 9886875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood pressure-independent reduction in proteinuria and arterial stiffness after acute endothelin-a receptor antagonism in chronic kidney disease.
    Dhaun N; Macintyre IM; Melville V; Lilitkarntakul P; Johnston NR; Goddard J; Webb DJ
    Hypertension; 2009 Jul; 54(1):113-9. PubMed ID: 19506099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of human retinal blood flow by endothelin-1.
    Polak K; Luksch A; Frank B; Jandrasits K; Polska E; Schmetterer L
    Exp Eye Res; 2003 May; 76(5):633-40. PubMed ID: 12697427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemodynamic and renal effects of endothelin receptor antagonism in patients with chronic kidney disease.
    Dhaun N; Ferro CJ; Davenport AP; Haynes WG; Goddard J; Webb DJ
    Nephrol Dial Transplant; 2007 Nov; 22(11):3228-34. PubMed ID: 17556408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of isradipine on renal haemodynamics and systemic blood pressure changes induced by intravenous infusion of endothelin in healthy humans.
    Sørensen SS; Jensen JD; Madsen JK; Pedersen EB
    Nephrol Dial Transplant; 1995; 10(8):1324-31. PubMed ID: 8538922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of endothelin and BQ123 on ocular blood flow parameters in healthy subjects.
    Polak K; Petternel V; Luksch A; Krohn J; Findl O; Polska E; Schmetterer L
    Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2949-56. PubMed ID: 11687541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fractional urinary excretion of endothelin-1 is reduced by acute ETB receptor blockade.
    Goddard J; Johnston NR; Cumming AD; Webb DJ
    Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1433-8. PubMed ID: 17855483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal hemodynamic effects of somatostatin are not related to inhibition of endogenous insulin release.
    Schmidt A; Pleiner J; Schaller G; Roden M; Dallinger S; Mayer G; Schmetterer L; Wolzt M
    Kidney Int; 2002 May; 61(5):1788-93. PubMed ID: 11967028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective ET(A) receptor antagonism with ABT-627 attenuates all renal effects of endothelin in humans.
    Honing MLH; Hijmering ML; Ballard DE; Yang YP; Padley RJ; Morrison PJ; Rabelink TJ
    J Am Soc Nephrol; 2000 Aug; 11(8):1498-1504. PubMed ID: 10906163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal vascular effects of the selective endothelin receptor antagonists in anaesthetized rats.
    Matsuura T; Miura K; Ebara T; Yukimura T; Yamanaka S; Kim S; Iwao H
    Br J Pharmacol; 1997 Sep; 122(1):81-6. PubMed ID: 9298531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective endothelin B receptor blockade does not influence BNP-induced natriuresis in man.
    van der Zander K; Houben AJ; Webb DJ; Udo E; Kietselaer B; Hofstra L; De Mey JG; de Leeuw PW
    Kidney Int; 2006 Mar; 69(5):864-8. PubMed ID: 16518347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.